Why the study?
Does pulmonary vasodilator therapy improve outcomes in pregnant women with pulmonary arterial hypertension?
Population
3 primiparous pregnant women with pulmonary arterial hypertension (PAH)
Design
Case_series
Follow-up
short-term (until discharge)
Authors
Loading...
High maternal risk persists in PAH pregnancy; leaves open vasodilator efficacy beyond small observational series.
Does pulmonary vasodilator therapy improve outcomes in pregnant women with pulmonary arterial hypertension?
Pulmonary vasodilator therapy may be used safely during pregnancy in women with PAH, potentially improving maternal and fetal prognoses despite the high risk of preterm delivery.
Daimon et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: